GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Henderson 89014: Nevada Weight Loss Wellness. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
Tirzepatide seen from Henderson 89014, without the jargon. Tirzepatide is the newest and most potent molecule in the incretin class: it is the first approved dual GIP/GLP-1 agonist, often chosen when semaglutide plateaus.
Price also shifts with the dose: the lowest titration steps usually cost less than the target maintenance dose. Some compounding pharmacies bill per vial, others per full program - comparing the 'all-in' cost avoids surprises at refill time.
With a local obesity rate around 30.6% and 11.0% uninsured, demand for Tirzepatide runs high around Henderson 89014. In this state, Nevada Revised Statutes §629.515; the reference body is Nevada State Board of Medical Examiners. Local landmark: Nevada Weight Loss Wellness (2501 N Green Valley Pkwy Suite 101D, Henderson, NV 89014), rated 5/5 across 2 reviews. Around Henderson 89014 in Clark County, 1 weight-management practice(s) are listed locally.
Yes: both are tirzepatide. Mounjaro is dosed/labeled for type 2 diabetes, Zepbound for weight management.
In the SURMOUNT head-to-head trials, tirzepatide produced greater average weight loss, likely thanks to its dual GIP + GLP-1 action. Response is individual and should be assessed by a physician.
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.